I understand where you're coming from, but since most of the data the FDA would want to see and decide on is collected, written up, analysed and interpreted by independent third parties, their opinion of PR's reliability is largely irrelevant, isn't it?
- Forums
- ASX - By Stock
- Why Zilosul could be a golden goose!!
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.67%
!
29.5¢

I understand where you're coming from, but since most of the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $114.8M |
Open | High | Low | Value | Volume |
30.0¢ | 30.5¢ | 29.5¢ | $37.97K | 127.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 96168 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 19879 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 96168 | 0.295 |
5 | 98339 | 0.290 |
6 | 115818 | 0.285 |
18 | 261166 | 0.280 |
5 | 151034 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 19879 | 4 |
0.305 | 24374 | 5 |
0.310 | 39104 | 5 |
0.315 | 94295 | 4 |
0.320 | 127866 | 10 |
Last trade - 13.43pm 23/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |